What Laboratorios Andrómaco does

Laboratorios Andrómaco S.A.I.C.I. is an Argentine pharmaceutical laboratory headquartered in Buenos Aires with a centenary operating history (founded circa 1924). The company manufactures and distributes a portfolio of pharmaceutical and dermocosmetic products organized around flagship brands Dermaglós (facial, body, sun protection, anti-aging, and acne care), Hipoglós (pediatric and wound/burn care, including the 80+ year-old Hipoglós VL dermal protector), Aveno (sensitive-skin cleansers and solar), Macril (dermatological creams and ovules), Bushi, and Prurisedán. Product formats span creams, serums, sunscreens, exfoliants, body oils, gels, and ovules, with formulations such as retinol, ectoína, glycolic/mandelic acids, and the proprietary vitamin A/benzalkonium/zinc oxide blend in Hipoglós VL.

The company's commercial model is a sales-led, pharmacy-anchored distribution system. A direct field force (Agentes de Propaganda Médica) covers pharmacies and healthcare providers nationwide; products flow through wholesale droguerías to an extensive retail pharmacy network, supplemented by a D2C e-commerce front (tienda.andromaco.com) that fulfills via partner pharmacies. Two gated professional portals — one for physicians, one for pharmacies — deliver training, scientific content, congress access, and the Cupón Andrómaco loyalty/coupon program (powered by Avanter's BonosDermo platform). Long-running partnerships with the Sociedad Argentina de Dermatología (26 national skin-cancer prevention campaigns) and the Sociedad Argentina de Gastroenterología (6 years of intestinal-parasitosis awareness) underpin credibility with prescribers and pharmacists.

Revenue is generated primarily through one-time OTC and prescription product sales across the brand portfolio, with transaction-fee economics on the online store front-end. The company is privately held with no disclosed PE/VC ownership, operates a 501–1,000 employee organization, and runs an "Internacional" export channel alongside continued domestic dominance. Active product development through 2022–2024 (Acné Control line, retinol and ectoína serums, Aveno cleansing foam, Hipoglós Q, Macril reformulations) points to ongoing portfolio renewal within the dermocosmetic core.

Name

Laboratorios Andrómaco

Legal name

Laboratorios Andrómaco S.A.I.C.I.

Website

https://andromaco.com

Company type

Private

Founded year

1924

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Laboratorios Andrómaco is a centenary Argentine pharmaceutical laboratory that manufactures and distributes dermocosmetic and therapeutic products — including Dermaglós, Hipoglós, and Aveno — through a nationwide pharmacy network and direct-to-consumer e-commerce, serving healthcare professionals and end consumers in Argentina.

Ownership category

akta.pro rank

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Revenue model

1. Pharmaceutical Product Sales: Sale of prescription and over-the-counter pharmaceutical products through pharmacy network and healthcare providers
2. Dermocosmetic Product Sales: Sale of cosmetic skincare products including sunscreens, moisturizers, anti-aging treatments, and specialty skincare through pharmacies and retail
3. Online Store Sales: Direct-to-consumer sales through online store (tienda.andromaco.com) where customers select products and purchase from partner pharmacies

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Laboratorios Andrómaco is an Argentine pharmaceutical laboratory that manufactures and distributes therapeutic and dermocosmetic products under established brands such as Dermaglós, Hipoglós, Aveno, Bushi, and Prurisedán. Its portfolio spans facial and body skincare, sun protection, anti-aging, acne control, sensitive skin care, wound healing, and pediatric care products sold primarily through an extensive pharmacy network across Argentina and through an owned online store.

Product overview

Laboratorios Andrómaco is an Argentine pharmaceutical laboratory with a portfolio of established dermocosmetics and therapeutic brands. The core brands include Dermaglós (comprehensive skincare including anti-aging, acne control, and sun protection), Hipoglós (80+ year-old brand for dermal protection and burn treatment), Aveno (sensitive skin specialist with cleansers and sunscreens), Bushi, Prurisedán, and Macril. Products span facial care (creams, serums, exfoliants), body care (oils, gels for scars), sun protection (SPF 30-50+), and specialized treatments (acne control, retinol, burn care). The company operates an e-commerce platform connected to a pharmacy network, and offers professional portals for healthcare providers and pharmacies with training materials and promotional resources.

Differentiator

Problem solved

Functional benefit

Brands

• Dermaglós: Dermocosmetics brand for skin care, including facial, corporal, and solar protection products.
• Hipoglós
• Aveno
• Bushi
• Prurisedán

Products and services

• Dermaglós Flagship dermocosmetics brand offering comprehensive skincare including facial care, body care, sun protection, anti-aging treatments, and acne control solutions for end consumers in Argentina.
• Hipoglós Established skincare brand with 80+ years of market presence, offering dermal protectors, burn treatments, and wound care products for children and adults.
• Aveno Skincare brand specialized in products for sensitive skin, featuring cleansers, moisturizers, and solar protection with hypoallergenic formulas.
• Bushi Skincare brand under the Laboratorios Andrómaco portfolio.
• Prurisedán Brand under the Andrómaco portfolio focused on pruritus (itching) relief products.
• Macril Brand offering Macril Crema and Macril Óvulos products for dermatological treatments including topical gynecological applications.
• Aveno Espuma de Limpieza Cleansing foam specifically formulated for sensitive skin, providing gentle daily facial cleansing for consumers with sensitive skin needs.
• Dermaglós Acné Control Complete line of acne treatment products designed for acne-prone skin, part of the Dermaglós brand expansion.
• Dermaglós Serum con Retinol Anti-aging serum containing retinol for skin regeneration and wrinkle reduction.
• Hipoglós Q Burn treatment cream, the latest addition to the Hipoglós line, formulated for burn wound care.
• Dermaglós Serum Ectoína Ectoína-based serum for skin barrier protection, preventing premature aging and strengthening skin barrier function.
• Dermaglós CC Cream Tono 1 Tinted moisturizing cream with color correction and sun protection, designed for daily facial use.
• Hipoglós VL Dermal protector ointment for local treatment of minor wounds, mild burns, contact dermatitis, and skin irritations. Contains vitamin A, benzalkonium chloride, and zinc oxide.
• Aveno Solar Sunscreen product line including facial and body sunscreens with SPF 50, offering broad-spectrum UVA, UVB and blue light protection with hypoallergenic, water-resistant formulas.
• Tienda Andrómaco Online store platform (tienda.andromaco.com) where consumers can browse and purchase Andrómaco products, with fulfillment handled by partner pharmacies.

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Sociedad Argentina de Dermatología (SAD)coreStrategic or Co-development PartnerLong-standing partnership for skin cancer prevention campaigns including the 26° Campaña Nacional de Prevención del Cáncer de Piel. Andrómaco and Dermaglós collaborate annually to support SAD's awareness initiatives reaching 200+ hospitals and clinics nationwide.
• Sociedad Argentina de Gastroenterología (SAGE)coreStrategic or Co-development PartnerSix-year partnership supporting the annual intestinal parasitosis prevention and awareness campaign. Andrómaco provides support for public education about prevention measures and treatment options for parasitic infections affecting children.
• CUI.D.AR Diabetes ArgentinaminorGTM or Marketing PartnerPartnership supporting the We.CONNECT Diabetes online marathon. Dermaglós brand sponsors the event providing diabetes education for patients, families, and healthcare professionals.
• Gobierno de la Ciudad de Buenos Aires (GCBA)minorStrategic or Co-development PartnerCollaboration on skin health education initiative targeting children to teach about skin care and sun protection from an early age.
• Avanter (BonosDermo Platform)coreTechnology or IntegrationTechnology partnership for Cupón Andrómaco pharmacy loyalty program. Avanter provides the BonosDermo platform that manages coupon distribution and pharmacy incentive programs.
• CED (Centro de Educación Digital)minorOthersReference to CED (Centro de Educación Digital) as a linked resource for healthcare professionals accessing through the Andrómaco professional portal.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Galderma: Global dermatology-focused pharmaceutical company (Cetaphil, Differin, Epiduo) selling through pharmacies and dermatologists. Represents the global dermatology leader that Andrómaco's Dermaglós brand competes with for dermatology prescription recommendations.
• Pierre Fabre (Avène / Ducray / A-Derma): French dermo-cosmetic laboratory specializing in sensitive skin, dermatology, and pharmacy-distributed skincare. Directly comparable business model to Andrómaco's Aveno and Dermaglós brands with similar pharmacy-channel distribution and dermatologist endorsements.
• Beiersdorf (Eucerin / Nivea): Global dermocosmetic giant whose Eucerin brand competes directly with Dermaglós in dermatology-recommended skincare. Represents the large multinational competitor that Andrómaco battles for pharmacy shelf space and dermatologist recommendations.
• Bayer (Consumer Health): Global pharmaceutical and consumer health company with OTC and skincare brands sold through pharmacies. Comparable as a multinational peer in OTC dermatology and consumer health categories where Andrómaco's Hipoglós and Macril products compete.
• L'Oréal (La Roche-Posay / Vichy): Global beauty leader with La Roche-Posay and Vichy as pharmacy-distributed dermocosmetic brands. Highly comparable to Andrómaco's positioning in pharmacy-distributed dermocosmetics, but with materially larger scale and marketing budget.

Direct peers

• Genomma Lab Internacional: Latin American pharmaceutical and personal care company with similar portfolio of OTC pharmaceutical and dermocosmetic brands. Competes directly with Andrómaco in Argentina across skincare and OTC categories with comparable pharmacy-distributed brand portfolios.
• Laboratorios Bagó: Argentine pharmaceutical laboratory with broad prescription and OTC portfolio including dermatology products. Comparable in scale, geographic focus, and pharmacy-channel go-to-market strategy within the Argentine market.
• Laboratorios Roemmers: Leading Argentine pharmaceutical laboratory with prescription drugs, OTC, and consumer health products. Directly comparable as a domestic Argentine pharma peer with similar pharmacy distribution model and dermatology-adjacent product portfolio.
• ISDIN: Spanish dermatology-focused company specializing in sunscreen, skincare, and dermo-cosmetic products sold through pharmacies. Highly comparable as a specialty dermocosmetic brand operating in the Iberian/Latin American pharmacy channel with sun care and sensitive skin focus.

Emerging players

• Cantabria Labs (IFC / Endocare): Spanish dermatology laboratory with pharmacy-distributed dermocosmetic brands including sunscreens and anti-aging skincare. Comparable to Andrómaco in product mix (sunscreens, anti-aging, dermatology-recommended products) and pharmacy distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@laboratoriosandromaco
• Facebookfacebook.com/LaboratoriosAndromaco
• LinkedInar.linkedin.com/company/laboratorios-andromaco
• Instagraminstagram.com/laboratoriosandromaco

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Andrómaco